This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Study Preview



Study Title and Description

Untitled



Key Questions Addressed
1 RCTs and other Comparative studies
  • Comments Comments (
    0
    ) |

Primary Publication Information
No primary publication information has been entered for this study.

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Studies
Arms
Number Title Description Comments
1 EPA sdfg;lskdfjg
  • Comments Comments (
    0
    ) |

Design Details
Question... Follow Up Answer Follow-up Answer


Baseline Characteristics
Question EPA Total Comments
AnswerFollow-up AnswerFollow-up
Baseline Diseases/Conditions No data entered.
Baseline characteristics, continuous No data entered.
Male, percent No data entered.
Race No data entered.
Comments about baseline data No data entered.
Baseline diet description No data entered.
Baseline omega-3 intake No data entered.
Does this study report baseline omega-3 biomarker data? No data entered.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Events (n) At Risk (N) Follow-up time Comments

Quality Dimensions
Dimension Value Notes Comments
Was the allocation sequence (RANDOMIZATION METHOD) adequately generated?
  • Comments Comments (
    0
    ) |
Was ALLOCATION adequately concealed (prior to assignment)?
  • Comments Comments (
    0
    ) |
Were PARTICIPANTS adequately BLINDED?
  • Comments Comments (
    0
    ) |
Were OUTCOME ASSESSORS adequately BLINDED?
  • Comments Comments (
    0
    ) |
Incomplete outcome data (ATTRITION BIAS) due to amount, nature or handling of incomplete outcome data
  • Comments Comments (
    0
    ) |
Is there evidence of SELECTIVE OUTCOME REPORTING bias (Yes/No)?
  • Comments Comments (
    0
    ) |
INTENTION-TO-TREAT analysis? (Yes/No)
  • Comments Comments (
    0
    ) |
Group SIMILARITY AT BASELINE (**GENERAL**)
  • Comments Comments (
    0
    ) |
Was there incomplete COMPLIANCE with interventions across groups?
  • Comments Comments (
    0
    ) |
Group SIMILARITY AT BASELINE (**OMEGA-3**)
  • Comments Comments (
    0
    ) |
Additional Bias: Bias due to problems not covered elsewhere in the table.
  • Comments Comments (
    0
    ) |
If outcome assessor blinding risk of bias is different for different outcomes (eg, lipids vs. MI), choose HIGH risk of bias and describe in Notes
  • Comments Comments (
    0
    ) |
If attrition risk of bias is different for different outcomes (eg, lipids vs. MI) or different time points (eg, 1 year vs. 5 years), choose HIGH risk of bias and describe in Notes
  • Comments Comments (
    0
    ) |

Quality Rating
No quality rating data was found.